子痫前期预防、预测的现状与关注焦点  

The Prevention and Prediction of Pre-Eclampsia:Recent Advances and the Way Forward

作　　者：吴志韦 林雪燕[1] 张雪芹 杨梅琳 WU Zhi-wei;LIN Xue-yan;ZHANG Xue-qin;YANG Mei-lin(Xiamen Key Laboratory of Basic and Clinical Research on Major Obstetric Diseases,Xiamen Perinatal Medicine Clinical Research Center,Department of Obstetrics,Women and Children′s Hospital,Xiamen University,Xiamen 361000,Fujian Province,China)

机构地区：[1]厦门市妇幼保健院、厦门大学附属妇女儿童医院产科、厦门市产科重大疾病基础与临床研究重点实验室、厦门市围产医学临床研究中心,361000

出　　处：《国际妇产科学杂志》2024年第3期312-316,共5页Journal of International Obstetrics and Gynecology

基　　金：厦门市医疗卫生指导性项目(3502Z20199075)。

摘　　要：子痫前期是导致孕产妇和围产儿死亡的重要原因之一,也影响母婴远期健康问题,是严重威胁母婴生命健康的重大公共卫生问题之一。梳理和分析阿司匹林在预防子痫前期方面的局限性及存在的争议,同时探讨其他药物在子痫前期防治中的作用;总结子痫前期在单胎和双胎妊娠中的预测方案,并着重强调三级医疗管理在子痫前期防治中的重要性。旨在进一步推动子痫前期高质量防治,提升妇幼健康水平。Pre-eclampsia is a leading cause of maternal and newborn mortality worldwide,impacting long-term health outcomes for both mother and child.We describe and analyze the limitations and controversies related to using aspirin for pre-eclampsia prevention,and explore the involvement of other medications in preventative strategies.Furthermore,this article examines the pre-eclampsia prediction scheme for both singleton and twin pregnancies,emphasizing the importance of tertiary referral systems in the prevention and treatment of pre-eclampsia,aiming to further promoting high-quality pre-eclampsia prevention and treatment and improve maternal and child health in China.

关 键 词：先兆子痫 化学预防 预测 阿司匹林 治疗 

分 类 号：R714.244[医药卫生—妇产科学]